Litigation Details for Actelion Pharmaceuticals US, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2023)
✉ Email this page to a colleague
Actelion Pharmaceuticals US, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2023)
Docket | ⤷ Sign Up | Date Filed | 2023-07-06 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | |
Jury Demand | None | Referred To | |
Patents | 8,791,122; 9,284,280 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Actelion Pharmaceuticals US, Inc. v. MSN Laboratories Private Ltd.
Details for Actelion Pharmaceuticals US, Inc. v. MSN Laboratories Private Ltd. (D. Del. 2023)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2023-07-06 | 3 | ANDA Form | of U.S. Patent No. 9,284,280: June 25, 2030. Date of Expiration of U.S. Patent No. 8,791,122: August … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 6 July 2023 1:23-cv-00731 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2023-07-06 | 4 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,791,122; 9,284,280. (twk) (… 6 July 2023 1:23-cv-00731 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |